Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Munro

Showing results (431-440 of 459) with videos related to

Pageof 46
Sort By:
International Psychogeriatrics|August 26, 2015
Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trialPaul B Rosenberg, Lea T Drye, Anton P Porsteinsson, et al.
Vaccine|October 12, 2021
A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, randomised, controlled, observer-blind studyCorinne Vandermeulen, Isabel Leroux-Roels, James Vandeleur, et al.
The American Journal of Psychiatry|January 16, 2016
Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical TrialLon S Schneider, Constantine Frangakis, Lea T Drye, et al.
Journal of Psychiatric Research|January 7, 2016
Sedation mediates part of Citalopram's effect on agitation in Alzheimer's diseaseJeffery Newell, Jerome A Yesavage, Joy L Taylor, et al.
The Lancet. Infectious Diseases|March 9, 2024
Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trialChijioke Bennett, Wayne Woo, Mark Bloch, et al.
Plos Pathogens|October 21, 2014
The pH-responsive PacC transcription factor of Aspergillus fumigatus governs epithelial entry and tissue invasion during pulmonary aspergillosisMargherita Bertuzzi, Markus Schrettl, Laura Alcazar-Fuoli, et al.
Journal of Psychiatric Research|April 27, 2016
Principal components analysis of agitation outcomes in Alzheimer's diseaseJerome A Yesavage, Joy L Taylor, Leah Friedman, et al.
The Journal of Infectious Diseases|July 25, 2024
Immunogenicity and Safety of Heterologous Omicron BA.1 and Bivalent SARS-CoV-2 Recombinant Spike Protein Booster Vaccines: A Phase 3 Randomized Clinical TrialChijioke Bennett, E Joy Rivers, Wayne Woo, et al.
Science Advances|December 6, 2024
Metasurface spectrometers beyond resolution-sensitivity constraintsFeng Tang, Jingjun Wu, Tom Albrow-Owen, et al.
Nucleic Acids Research|July 9, 2018
Generating genomic platforms to study Candida albicans pathogenesisMélanie Legrand, Sophie Bachellier-Bassi, Keunsook K Lee, et al.
Pageof 46

Showing results (431-440 of 459) with videos related to

Sort By:
Pageof 46
International Psychogeriatrics|August 26, 2015
Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trialPaul B Rosenberg, Lea T Drye, Anton P Porsteinsson, et al.
Vaccine|October 12, 2021
A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, randomised, controlled, observer-blind studyCorinne Vandermeulen, Isabel Leroux-Roels, James Vandeleur, et al.
The American Journal of Psychiatry|January 16, 2016
Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical TrialLon S Schneider, Constantine Frangakis, Lea T Drye, et al.
Journal of Psychiatric Research|January 7, 2016
Sedation mediates part of Citalopram's effect on agitation in Alzheimer's diseaseJeffery Newell, Jerome A Yesavage, Joy L Taylor, et al.
The Lancet. Infectious Diseases|March 9, 2024
Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trialChijioke Bennett, Wayne Woo, Mark Bloch, et al.
Plos Pathogens|October 21, 2014
The pH-responsive PacC transcription factor of Aspergillus fumigatus governs epithelial entry and tissue invasion during pulmonary aspergillosisMargherita Bertuzzi, Markus Schrettl, Laura Alcazar-Fuoli, et al.
Journal of Psychiatric Research|April 27, 2016
Principal components analysis of agitation outcomes in Alzheimer's diseaseJerome A Yesavage, Joy L Taylor, Leah Friedman, et al.
The Journal of Infectious Diseases|July 25, 2024
Immunogenicity and Safety of Heterologous Omicron BA.1 and Bivalent SARS-CoV-2 Recombinant Spike Protein Booster Vaccines: A Phase 3 Randomized Clinical TrialChijioke Bennett, E Joy Rivers, Wayne Woo, et al.
Science Advances|December 6, 2024
Metasurface spectrometers beyond resolution-sensitivity constraintsFeng Tang, Jingjun Wu, Tom Albrow-Owen, et al.
Nucleic Acids Research|July 9, 2018
Generating genomic platforms to study Candida albicans pathogenesisMélanie Legrand, Sophie Bachellier-Bassi, Keunsook K Lee, et al.
Pageof 46